- Home
- NAT vs LXEO Comparison
NAT vs LXEO Comparison
Compare NAT & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAT | LXEO |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 669.1M | 663.5M |
| IPO Year | 1997 | 2023 |
Fundamental Metrics
Financial Performance| Metric | NAT | LXEO |
|---|---|---|
| Price | $3.38 | $10.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $3.25 | ★ $18.90 |
| AVG Volume (30 Days) | ★ 2.9M | 1.5M |
| Earning Date | 11-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 10.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $294,820,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $32.00 | N/A |
| P/E Ratio | $374.40 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $1.45 |
| 52 Week High | $3.93 | $10.79 |
Technical Indicators
Market Signals| Indicator | NAT | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 35.47 | 61.84 |
| Support Level | $3.34 | $9.04 |
| Resistance Level | $3.78 | $10.56 |
| Average True Range (ATR) | 0.10 | 0.62 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 7.96 | 84.14 |
Price Performance
Historical ComparisonAbout NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.